Compare KYNB & FRTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KYNB | FRTT |
|---|---|---|
| Founded | 1993 | N/A |
| Country | United States | Canada |
| Employees | 34 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 24.0M |
| IPO Year | N/A | N/A |
| Metric | KYNB | FRTT |
|---|---|---|
| Price | $7.31 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.6K | ★ 4.5M |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.32 | $0.72 |
| 52 Week High | $9.58 | $3.92 |
| Indicator | KYNB | FRTT |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 28.24 |
| Support Level | $6.59 | $0.82 |
| Resistance Level | $7.41 | $1.43 |
| Average True Range (ATR) | 0.30 | 0.19 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 53.68 | 25.18 |
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.